Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2005
04/27/2005CN1198926C Nucleic acid fragments, recombinant vector containing the same method for promoting expression of structural gene by using the same
04/27/2005CN1198925C Method for prolonged storage of DNA molecules and packaging implementing said method
04/27/2005CN1198924C Expression cloning in filamentous fungi
04/27/2005CN1198923C Thermostable endo-beta-1,4-glucanase
04/27/2005CN1198921C Raffinose synthetase gene, process for producing, raffinose and transformed plant
04/27/2005CN1198919C Method of producing L-serine by fermentation
04/27/2005CN1198918C Live attenuated bacteria of species actinobacillus pleuropneumoniae
04/27/2005CN1198913C Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in the active site loop region
04/27/2005CN1198912C Bleaching compositions comprising multiply-substd, protease variants
04/27/2005CN1198844C Process of high purity albumin production
04/27/2005CN1198842C Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity
04/27/2005CN1198840C Human papillomavirus 11L1-E7 recombinant protein and its application
04/27/2005CN1198837C Purification of tissue plasminogen activator (tPA)
04/27/2005CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory
04/27/2005CN1198648C High affinity human monoclonal antibodies specific for RSV F-protein
04/27/2005CN1198647C Antibodies against human CD40
04/27/2005CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
04/27/2005CN1198642C Pharmaceutical application of mammal cell kinetin synthetic inhibitory factor
04/27/2005CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof
04/26/2005US6884931 Rice hybrid RH101
04/26/2005US6884921 Cell for use in the generation of prefrential plant enzymatic polypeptide
04/26/2005US6884879 Anti-VEGF antibodies
04/26/2005US6884787 Antisense modulation of transforming growth factor-beta 3 expression
04/26/2005US6884786 Antitumoral composition based on immunogenic polypeptide with modified cell location
04/26/2005US6884779 Hybrid screening analyzing
04/26/2005US6884775 Methods and compositions for regulating skeletogenic formation
04/26/2005US6884771 Genes codes for peptidyldipeptidase A, used for therapy, medical prognosis and diagnosis of hypertension
04/26/2005US6884629 Immunoglobulin binding protein
04/26/2005US6884623 Using plant virions for vaccine preparation; gene therapy
04/26/2005US6884622 Method for preparing a mammalian cell deficient in HPRT
04/26/2005US6884620 Genetic engineering
04/26/2005US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
04/26/2005US6884617 Comprises nucleotide sequences coding myogenic factors for diagnosis and treatment of cell proliferative and muscular disorders
04/26/2005US6884616 DNA-construct for the tissue-specific expression of a blood coagulation factor
04/26/2005US6884614 Comprises nucleotide sequences coding sucrose transport modulating enzymatic polypeptide for use in preparing animal feeds, cosmetic and foods
04/26/2005US6884613 Purification of preferential viral particles; obtain solution containing viral particles, mix with polyelectrolyte, centrifuge, recover pellet, separate viral particles from pellet
04/26/2005US6884612 Lambdoid bacteriophage vectors for expression of foreign proteins
04/26/2005US6884609 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
04/26/2005US6884607 Coded amino acid sequence being an amino acid sequence of a protein capable of producing 4-bromo-3-hydroxy butanoate by asymmetrically reducing 4-bromo-3-oxobutanoate
04/26/2005US6884604 Generation of random nucleotide sugar libraries for use in the generation of coumarin and ertyhronilide derivatives; obtain nucleotide sugar, incubate with glycosyltransferase, recover glycosylated product
04/26/2005US6884602 Expression of alkaline phosphatase in yeast
04/26/2005US6884598 Screening for modulator of receptor binding activity; obtain cells, incubate with modulator, monitor cell response
04/26/2005US6884595 Test tumor cell modulation; analyzing chromosomes
04/26/2005US6884594 Antibodies to growth factor HTTER36
04/26/2005US6884586 Methylation analysis using nicking agents
04/26/2005US6884584 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
04/26/2005US6884582 Using photothermography to identify protein/ligand interactions; rational drug design and discovery
04/26/2005US6884576 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases
04/26/2005US6884575 Diagnosis and treatment of insulin resistance in diabetics; obtain humans, administer modulator of insulin resistance, monitor human response to insulin
04/26/2005US6884574 Methods of identifying agents which inhibit GPR-9-6
04/26/2005US6884431 Method for treating proliferative diseases with p27 and fusions thereof
04/26/2005US6884414 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
04/26/2005CA2360376C Novel carbonyl reductase, gene thereof and method of using the same
04/26/2005CA2310854C Isolation and identification of novel polymerases
04/26/2005CA2253871C Ret ligand (retl) for stimulating neural and renal growth
04/26/2005CA2165954C Prostaglandin receptor fp and dna encoding it
04/26/2005CA2152505C Method for preparing a viral aerosol
04/26/2005CA2103573C Stamen-specific promoters from rice
04/26/2005CA1341481C Transformation and foreign gene expression in brassica species
04/21/2005WO2005036442A1 DEVICE AND METHOD FOR PREDICTING RNAi EFFECT IN siRNA
04/21/2005WO2005035789A1 Primer for detecting alicyclobacillus
04/21/2005WO2005035778A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF α1,6-FUCOSYLTRANSFERASE
04/21/2005WO2005035774A1 Process for producing scyllo-inositol
04/21/2005WO2005035773A2 Modified cea /b7 vector
04/21/2005WO2005035772A1 Simplified method for producing therapeutic viral vectors which are free of marker genes in their therapeutically suitable form
04/21/2005WO2005035771A2 Nucleic acid constructs
04/21/2005WO2005035770A1 A root-preferred maize promoter named crwaq81
04/21/2005WO2005035769A2 Gene silencing by using micro-rna molecules
04/21/2005WO2005035768A1 Expression of biologically active polypeptides in duckweed
04/21/2005WO2005035767A1 Alpha interferon variants
04/21/2005WO2005035766A1 Promoter for the epidermis-specific transgenic expression in plants
04/21/2005WO2005035765A1 Method of inhibiting interferon response
04/21/2005WO2005035764A1 Autogene nucleic acids encoding a secretable rna polymerase
04/21/2005WO2005035763A1 Nucleotide sequences and polypeptides encoded thereby useful for producting transformed plants expressing lethal/nonviability genes
04/21/2005WO2005035762A1 Cytokine involved in epithelial-mesenchymal transition
04/21/2005WO2005035761A1 Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin
04/21/2005WO2005035760A2 Molecular nanomotor
04/21/2005WO2005035759A2 RNA INTERFERENCE MEDIATED INHIBITION OF HYPOXIA INDUCIBLE FACTOR 1 (HIF1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
04/21/2005WO2005035758A1 Purification of biological macromolecules
04/21/2005WO2005035757A1 A process for sequence saturation mutagenesis (sesam)
04/21/2005WO2005035755A1 Method of introducing nucleic acid
04/21/2005WO2005035752A2 Materials and methods for synthesis of a flavor and aroma volatile in plants
04/21/2005WO2005035751A1 Method of quickly and efficiently selecting high-functioning protein, high-functioning protein thus obtained, method of producing the same and method of using the same
04/21/2005WO2005035747A1 Protease variants
04/21/2005WO2005035744A1 Tumor targeting two genes-virus, the methods to construct it and the use thereof
04/21/2005WO2005035743A1 Method for large-scale production, isolation, purification and the uses of multi-type recombinant adeno-associated virus vectors
04/21/2005WO2005035741A1 Genomically modified cell
04/21/2005WO2005035740A1 Genomically modified cell neutralized to serum-free system
04/21/2005WO2005035730A2 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain
04/21/2005WO2005035718A2 Biderectional promoters for small rna expression
04/21/2005WO2005035715A2 Flanking dna sequences that control expression in the human genome
04/21/2005WO2005035712A2 Methods and compositions for infectious cdna of sars coronavirus
04/21/2005WO2005035585A1 Support having affinity for antibody
04/21/2005WO2005035583A1 Antibody composition specifically binding to il-5 receptor
04/21/2005WO2005035582A1 Composition of antibody capable of specifically binding ccr4
04/21/2005WO2005035581A1 COMPOSITION OF ANTIBODY CAPABLE OF SPECIFICALLY BINDING HUMAN VEGF RECEPTOR Flt-1
04/21/2005WO2005035580A1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
04/21/2005WO2005035579A1 A method for the treatment of maligant diseases by inhibiting nucleolin
04/21/2005WO2005035578A1 Antibody composition specifically binding to ganglioside gm2
04/21/2005WO2005035577A1 Antibody composition specifically binding to ganglioside gd3
1 ... 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 ... 4023